Literature DB >> 26002081

Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Julia Kravchenko1, Emanuela Corsini2, Marc A Williams3, William Decker4, Masoud H Manjili5, Takemi Otsuki6, Neetu Singh7, Faha Al-Mulla8, Rabeah Al-Temaimi8, Amedeo Amedei9, Anna Maria Colacci10, Monica Vaccari10, Chiara Mondello11, A Ivana Scovassi11, Jayadev Raju12, Roslida A Hamid13, Lorenzo Memeo14, Stefano Forte14, Rabindra Roy15, Jordan Woodrick15, Hosni K Salem16, Elizabeth P Ryan17, Dustin G Brown17, William H Bisson18, Leroy Lowe19, H Kim Lyerly20.   

Abstract

An increasing number of studies suggest an important role of host immunity as a barrier to tumor formation and progression. Complex mechanisms and multiple pathways are involved in evading innate and adaptive immune responses, with a broad spectrum of chemicals displaying the potential to adversely influence immunosurveillance. The evaluation of the cumulative effects of low-dose exposures from the occupational and natural environment, especially if multiple chemicals target the same gene(s) or pathway(s), is a challenge. We reviewed common environmental chemicals and discussed their potential effects on immunosurveillance. Our overarching objective was to review related signaling pathways influencing immune surveillance such as the pathways involving PI3K/Akt, chemokines, TGF-β, FAK, IGF-1, HIF-1α, IL-6, IL-1α, CTLA-4 and PD-1/PDL-1 could individually or collectively impact immunosurveillance. A number of chemicals that are common in the anthropogenic environment such as fungicides (maneb, fluoxastrobin and pyroclostrobin), herbicides (atrazine), insecticides (pyridaben and azamethiphos), the components of personal care products (triclosan and bisphenol A) and diethylhexylphthalate with pathways critical to tumor immunosurveillance. At this time, these chemicals are not recognized as human carcinogens; however, it is known that they these chemicalscan simultaneously persist in the environment and appear to have some potential interfere with the host immune response, therefore potentially contributing to promotion interacting with of immune evasion mechanisms, and promoting subsequent tumor growth and progression.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26002081      PMCID: PMC4565606          DOI: 10.1093/carcin/bgv033

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  254 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  WILLIAM BRADLEY COLEY 1862-1936.

Authors:  C G Burdick
Journal:  Ann Surg       Date:  1937-01       Impact factor: 12.969

3.  Induction of apoptosis and cell cycle arrest by Bis (2-ethylhexyl) phthalate produced by marine Bacillus pumilus MB 40.

Authors:  A Moushumi Priya; S Jayachandran
Journal:  Chem Biol Interact       Date:  2011-12-03       Impact factor: 5.192

Review 4.  Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.

Authors:  Amedeo Amedei; Elena Niccolai; Domenico Prisco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

6.  Profiling bioactivity of the ToxCast chemical library using BioMAP primary human cell systems.

Authors:  Keith A Houck; David J Dix; Richard S Judson; Robert J Kavlock; Jian Yang; Ellen L Berg
Journal:  J Biomol Screen       Date:  2009-09-22

7.  Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression.

Authors:  Almudena Veiga-Lopez; Lacey J Luense; Lane K Christenson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2013-03-22       Impact factor: 4.736

8.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

9.  Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.

Authors:  A Inoue; Y Omoto; Y Yamaguchi; R Kiyama; S-I Hayashi
Journal:  J Mol Endocrinol       Date:  2004-06       Impact factor: 5.098

10.  Insights into yeast adaptive response to the agricultural fungicide mancozeb: a toxicoproteomics approach.

Authors:  Pedro M Santos; Tânia Simões; Isabel Sá-Correia
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

View more
  15 in total

1.  Effect of estrogen-active compounds on the expression of RACK1 and immunological implications.

Authors:  Erica Buoso; Mirco Masi; Valentina Galbiati; Ambra Maddalon; Martina Iulini; Maša Kenda; Marija Sollner Dolenc; Marina Marinovich; Marco Racchi; Emanuela Corsini
Journal:  Arch Toxicol       Date:  2020-04-23       Impact factor: 5.153

Review 2.  Potential of MALDI imaging for the toxicological evaluation of environmental pollutants.

Authors:  Mélanie Lagarrigue; Richard M Caprioli; Charles Pineau
Journal:  J Proteomics       Date:  2016-05-10       Impact factor: 4.044

Review 3.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

4.  Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.

Authors:  Jinquan Cai; Qun Chen; Yuqiong Cui; Jiawei Dong; Meng Chen; Pengfei Wu; Chuanlu Jiang
Journal:  Oncoimmunology       Date:  2018-02-13       Impact factor: 8.110

5.  Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.

Authors:  Luis Miguel Guamán-Ortiz; Maria Isabel Ramirez Orellana; Edward A Ratovitski
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

6.  A Perspective Discussion on Rising Pesticide Levels and Colon Cancer Burden in Brazil.

Authors:  Sergio Akira Uyemura; Helga Stopper; Francis L Martin; Vinicius Kannen
Journal:  Front Public Health       Date:  2017-10-16

7.  Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens.

Authors:  Miriam N Jacobs; Annamaria Colacci; Raffaella Corvi; Monica Vaccari; M Cecilia Aguila; Marco Corvaro; Nathalie Delrue; Daniel Desaulniers; Norman Ertych; Abigail Jacobs; Mirjam Luijten; Federica Madia; Akiyoshi Nishikawa; Kumiko Ogawa; Kiyomi Ohmori; Martin Paparella; Anoop Kumar Sharma; Paule Vasseur
Journal:  Arch Toxicol       Date:  2020-06-27       Impact factor: 5.153

8.  Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.

Authors:  Binghao Zhao; Yuekun Wang; Yaning Wang; Congxin Dai; Yu Wang; Wenbin Ma
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

9.  Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations.

Authors:  Mark F Miller; William H Goodson; Masoud H Manjili; Nicole Kleinstreuer; William H Bisson; Leroy Lowe
Journal:  Environ Health Perspect       Date:  2016-08-12       Impact factor: 9.031

10.  Curation of cancer hallmark-based genes and pathways for in silico characterization of chemical carcinogenesis.

Authors:  Peir-In Liang; Chia-Chi Wang; Hsien-Jen Cheng; Shan-Shan Wang; Ying-Chi Lin; Pinpin Lin; Chun-Wei Tung
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.